211 related articles for article (PubMed ID: 35131371)
1. Iontophoresis-mediated direct delivery of nucleic acid therapeutics, without use of carriers, to internal organs via non-blood circulatory pathways.
Hasan M; Fukuta T; Inoue S; Mori H; Kagawa M; Kogure K
J Control Release; 2022 Mar; 343():392-399. PubMed ID: 35131371
[TBL] [Abstract][Full Text] [Related]
2. [Drug Delivery to Various Body Organs via Non-blood Circulatory Pathway].
Kogure K; Fukuta T
Yakugaku Zasshi; 2020; 140(5):611-615. PubMed ID: 32378660
[TBL] [Abstract][Full Text] [Related]
3. Overcoming thickened pathological skin in psoriasis via iontophoresis combined with tight junction-opening peptide AT1002 for intradermal delivery of NF-κB decoy oligodeoxynucleotide.
Fukuta T; Tanaka D; Inoue S; Michiue K; Kogure K
Int J Pharm; 2021 Jun; 602():120601. PubMed ID: 33905867
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive delivery of biological macromolecular drugs into the skin by iontophoresis and its application to psoriasis treatment.
Fukuta T; Oshima Y; Michiue K; Tanaka D; Kogure K
J Control Release; 2020 Jul; 323():323-332. PubMed ID: 32360305
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive transdermal delivery of liposomes by weak electric current.
Hasan M; Khatun A; Fukuta T; Kogure K
Adv Drug Deliv Rev; 2020; 154-155():227-235. PubMed ID: 32589904
[TBL] [Abstract][Full Text] [Related]
6. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
7. Use of Iontophoresis Technology for Transdermal Delivery of a Minimal mRNA Vaccine as a Potential Melanoma Therapeutic.
Husseini RA; Abe N; Hara T; Abe H; Kogure K
Biol Pharm Bull; 2023; 46(2):301-308. PubMed ID: 36724958
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis.
Toyoda M; Hama S; Ikeda Y; Nagasaki Y; Kogure K
Int J Pharm; 2015 Apr; 483(1-2):110-4. PubMed ID: 25681719
[TBL] [Abstract][Full Text] [Related]
9. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive approach for enhancing small interfering RNA delivery percutaneously.
Aljuffali IA; Lin YK; Fang JY
Expert Opin Drug Deliv; 2016; 13(2):265-80. PubMed ID: 26592090
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma.
Labala S; Jose A; Venuganti VV
Colloids Surf B Biointerfaces; 2016 Oct; 146():188-97. PubMed ID: 27318964
[TBL] [Abstract][Full Text] [Related]
12. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
13. Faint electric treatment-induced rapid and efficient delivery of extraneous hydrophilic molecules into the cytoplasm.
Hasan M; Nishimoto A; Ohgita T; Hama S; Kashida H; Asanuma H; Kogure K
J Control Release; 2016 Apr; 228():20-25. PubMed ID: 26944781
[TBL] [Abstract][Full Text] [Related]
14. Advances in modification and delivery of nucleic acid drugs.
Wang J; Tan M; Wang Y; Liu X; Lin A
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):417-428. PubMed ID: 37643976
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
Bartlett DW; Davis ME
Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672
[TBL] [Abstract][Full Text] [Related]
16. Trials and tribulations of skin iontophoresis in therapeutics.
Roustit M; Blaise S; Cracowski JL
Br J Clin Pharmacol; 2014 Jan; 77(1):63-71. PubMed ID: 23590287
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
18. Iontophoresis-driven porous microneedle array patch for active transdermal drug delivery.
Li Y; Yang J; Zheng Y; Ye R; Liu B; Huang Y; Zhou W; Jiang L
Acta Biomater; 2021 Feb; 121():349-358. PubMed ID: 33340733
[TBL] [Abstract][Full Text] [Related]
19. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid delivery: the missing pieces of the puzzle?
Nguyen J; Szoka FC
Acc Chem Res; 2012 Jul; 45(7):1153-62. PubMed ID: 22428908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
